Azoulay Salomon
SEC insider (Form 3/4/5 filer). CIK 0002030246. Chief Medical Officer at MBX Biosciences, Inc. (MBX). 9 reported Form 4/5 transactions since Sep 2024; latest on Aug 4, 2026. Located in CARMEL, IN.
Companies Azoulay Salomon has filed insider reports for
- MBX Biosciences, Inc. (MBX): Officer, Chief Medical Officer
Azoulay Salomon
CIK: 0002030246
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MBX Biosciences, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Aug 4, 2026MBX
MBX Biosciences, Inc.
SaleDirect370 shares at avg. $65.77$24K - May 8, 2026MBX
MBX Biosciences, Inc.
ExerciseDirect55K shares at avg. $10.46$575K - May 8, 2026MBX
MBX Biosciences, Inc.
SaleDirect55K shares at avg. $38.38$2.1M - May 8, 2026MBX
MBX Biosciences, Inc.
ExerciseDirect15K shares at avg. $16.00$240K - May 8, 2026MBX
MBX Biosciences, Inc.
SaleDirect15K shares at avg. $38.30$575K - May 6, 2026MBX
MBX Biosciences, Inc.
SaleDirect231 shares at avg. $29.54$7K - Feb 2, 2026MBX
MBX Biosciences, Inc.
AwardDirect15K shares- - Feb 3, 2025MBX
MBX Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
90K shares- - Sep 12, 2024MBX
MBX Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
45K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 4, 2026 | MBX MBX Biosciences, Inc. | Sale | 370 | $65.77 | $24,335 | Direct |
| May 8, 2026 | MBX MBX Biosciences, Inc. | Exercise | 55,000 | $10.46 | $575,300 | Direct |
| May 8, 2026 | MBX MBX Biosciences, Inc. | Sale | 55,000 | $38.38 | $2,110,900 | Direct |
| May 8, 2026 | MBX MBX Biosciences, Inc. | Exercise | 15,003 | $16.00 | $240,048 | Direct |
| May 8, 2026 | MBX MBX Biosciences, Inc. | Sale | 15,003 | $38.30 | $574,615 | Direct |
| May 6, 2026 | MBX MBX Biosciences, Inc. | Sale | 231 | $29.54 | $6,824 | Direct |
| Feb 2, 2026 | MBX MBX Biosciences, Inc. | Award | 15,000 | - | $0 | Direct |
| Feb 3, 2025 | MBX MBX Biosciences, Inc. | Award Stock Option (Right to Buy) | 90,000 | - | - | Direct |
| Sep 12, 2024 | MBX MBX Biosciences, Inc. | Award Stock Option (Right to Buy) | 45,011 | - | - | Direct |
1-9 of 9 transactions